Skip to content
Screener

Innoviva, Inc. INVA Return on equity

Return on equity at other companies

Pfizer logo
PfizerPFE
10.6%
Merck & Co. logo
Merck & Co.MRK
7%-28.5pp
AbbVie logo
AbbVieABBV
89%+32.7pp
Insmed logo
InsmedINSM
-87.2%-27.3pp
Savara logo
SavaraSVRA
-80%+4.7pp
ArriVent BioPharma, Inc. logo
ArriVent BioPharma, Inc.AVBP
-55.2%+8.0pp

Other financials

Income statement

See full
Revenue$119.6M+19.3%
Gross profit$90.6M+9.0%
Operating income$50.9M+4.3%
Net income-$83.4M-231%
EPS (diluted)-$1.14-248%

Balance sheet

See full
Cash & equivalents$570.4M+43.5%
Total debt$269.7M-40.2%
Total equity$1.2B
Total assets$1.7B+27.7%

Cash flow

See full
Operating cash flow$52.0M+17.9%
CapEx$429.0K
Free cash flow$51.5M+16.9%

Valuation

See full
Market cap$1.53B+33.1%
Enterprise value$1.22B+2.1%
P/E4.3×-25.4×
P/S3.5×+0.4×

Profitability

See full
Gross margin72.2%-10.9pp
Operating margin36.9%-10.7pp
Net margin81.2%+70.8pp
FCF margin43.1%-11.1pp

Returns & leverage

See full
Debt / equity0.2×
Current ratio16×+13.4×

Where this comes from

Calculated from Innoviva, Inc.’s reported figures.

Based on trailing twelve months.

The source filing: Innoviva, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:26 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001193125-26-335235

FAQ

What is Innoviva, Inc.'s return on equity?
Innoviva, Inc. (INVA) reported return on equity of 29.1% in Q4 2025.
What is the long-term trend for Innoviva, Inc.'s return on equity?
Over 2 years (2020 to 2025), Innoviva, Inc.'s return on equity has grown at a -35.0% compound annual growth rate (CAGR), from 68.9% to 29.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.

Ask your AI about Innoviva, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude